Hasanov, E., Faieta, A., Majeed, Z., Mammadzada, N., Bicer, F., Folefac, E., Monk, P., Singer, E. A., Shabsigh, A., Mortazavi, A., Hasanov, M., Clinton, S. K. (2026). Real-world overall survival outcomes of lutetium (Lu 177 ) vipivotide tetraxetan treatment in prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5033